Gentiva Health Services
The 10-second takeaway
For the quarter ended March 31 (Q1), Gentiva Health Services met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share dropped significantly.
Margins shrank across the board.
Gentiva Health Services chalked up revenue of $435.7 million. The nine analysts polled by S&P Capital IQ expected to see net sales of $437.0 million on the same basis. GAAP reported sales were 5.0% lower than the prior-year quarter's $458.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.24. The seven earnings estimates compiled by S&P Capital IQ predicted $0.28 per share. GAAP EPS of $0.16 for Q1 were 64% lower than the prior-year quarter's $0.44 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 46.5%, 220 basis points worse than the prior-year quarter. Operating margin was 6.7%, 470 basis points worse than the prior-year quarter. Net margin was 1.1%, 180 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $437.9 million. On the bottom line, the average EPS estimate is $0.27.
Next year's average estimate for revenue is $1.75 billion. The average EPS estimate is $1.14.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 296 members out of 311 rating the stock outperform, and 15 members rating it underperform. Among 94 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 90 give Gentiva Health Services a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $7.17.
If you're interested in health-care stocks like Gentiva Health Services, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add Gentiva Health Services to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.